Evolution and epidemiology of extended-spectrum β-lactamases (ESBLs) and ESBL-producing microorganisms
- 1 November 2001
- journal article
- review article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 7 (11) , 597-608
- https://doi.org/10.1046/j.1198-743x.2001.00330.x
Abstract
No abstract availableKeywords
This publication has 144 references indexed in Scilit:
- Ceftriaxone-Resistant Salmonella Infection Acquired by a Child from CattleNew England Journal of Medicine, 2000
- Characterization and amino acid sequence analysis of a new oxyimino cephalosporin-hydrolyzing class A β-lactamase from Serratia fonticola CUVBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1997
- Is it important to identify extended-spectrum beta-lactamase-producing isolates?European Journal of Clinical Microbiology & Infectious Diseases, 1996
- Evolution of antibiotic resistance: several different amino acid substitutions in an active site loop alter the substrate profile of β‐lactamaseMolecular Microbiology, 1994
- Spread ofklebsiella pneumoniae producing SHV-5 beta-lactamase among hospitalized patientsInfection, 1993
- A new plasmidic cefotaximase from patients infected withSalmonella typhimuriumInfection, 1992
- An IS1-like element is responsible for high-level synthesis of extended-spectrum -lactamase TEM-6 in EnterobacteriaceaeJournal of General Microbiology, 1991
- Epidemiology of extended spectrum β-lactamasesInfection, 1989
- Single amino acid substitution between SHV‐1 β‐lactamase and cefotaxime‐hydrolyzing SHV‐2 enzymeFEBS Letters, 1988
- TRANSFERABLE ENZYMATIC RESISTANCE TO THIRD-GENERATION CEPHALOSPORINS DURING NOSOCOMIAL OUTBREAK OF MULTIRESISTANT KLEBSIELLA PNEUMONIAEThe Lancet, 1987